The Genomics Market is increasingly influencing modern healthcare by enabling more precise approaches to disease detection, risk assessment, and treatment selection. Clinical diagnostics is one of the most important application areas, with genomic testing being increasingly applied to oncology, rare diseases, inherited disorders, and prenatal screening.

Market Research Future estimates that the global genomics market was worth USD 30.15 billion in 2025 and is forecast to reach USD 84.30 billion by 2035, representing a CAGR of 10.80% during 2026–2035.

Diagnostics accounted for 32.4% of genomics market revenue in 2025, making it the leading application segment. Oncology panels and non-invasive prenatal testing are among the key contributors to diagnostic demand.

Genomic diagnostics can provide information that traditional diagnostic approaches may not capture. In cancer care, genomic profiling can help identify molecular alterations associated with specific tumors and support the selection of targeted treatment options. In rare diseases, sequencing can assist physicians and researchers in identifying genetic variants that may explain unexplained clinical conditions.

The growing availability of genetic testing is also supporting market expansion. Improvements in sequencing platforms, laboratory workflows, and bioinformatics tools are making genomic testing more practical for diagnostic laboratories. As healthcare providers gain greater access to genomic information, demand for interpretation and data-analysis services is expected to increase.

Another important trend is the integration of genomics with personalized medicine. Precision medicine aims to tailor healthcare decisions according to patient-specific characteristics, including genetic information. Market Research Future expects precision and personalized medicine to record a 13.1% CAGR through 2035, making it one of the fastest-growing application areas.

AI is expected to further strengthen clinical genomics. Genomic datasets can contain millions of genetic variants, creating challenges for manual interpretation. AI and machine-learning technologies can help laboratories prioritize potentially significant variants and streamline analytical workflows.

Diagnostic and reference laboratories represented the largest end-user category, accounting for 36.8% of the market in 2025. Pharmaceutical and biotechnology companies are also expected to experience strong growth as genomic information becomes increasingly important in drug development and companion diagnostics.

Overall, the increasing integration of genomic testing into clinical diagnostics is expected to remain a major market driver. Continued improvements in sequencing accuracy, affordability, interpretation, and reimbursement could further expand access to genomic healthcare.